• 1
    Maclure M. Demonstration of deductive meta-analysis: ethanol intake and risk of myocardial infarction. Epidemiol Rev. 1993;15:328351.
  • 2
    Rimm EB, Giovannucci EL, Willett WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 1991;338:464468.
  • 3
    Stampfer MJ, Colditz GA, Willett WC, et al. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med. 1988;319:267273.
  • 4
    McElduff P, Dobson AJ. How much alcohol and how often? Population based case-control study of alcohol consumption and risk of a major coronary event. BMJ. 1997;314:11591164.
  • 5
    Yuan JM, Ross RK, Gao YT, et al. Follow up study of moderate alcohol intake and mortality among middle-aged men in Shanghai, China. BMJ. 1997;314:1823.
  • 6
    Doll R, Peto R, Hall E, et al. Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. BMJ. 1994;309:911918.
  • 7
    Colditz GA, Branch LG, Lipnick RJ, et al. Moderate alcohol and decreased cardiovascular mortality in an elderly cohort. Am Heart J. 1985;109:886889.
  • 8
    Rimm E. Alcohol and coronary heart disease: can we learn more? Epidemiology. 2001;12:380382.
  • 9
    Friedman HS, Lieber CS. Alcohol and the heart. In: FeldmanEB, ed. Nutrition and Heart Disease. New York , NY : Churchill Livingstone; 1983:158.
  • 10
    Criqui M. Alcohol in the myocardial infarction patient. Lancet. 1998;352:1873.
  • 11
    Rimm EB, Williams P, Fosher K, et al. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999;319:15231528.
  • 12
    Ellison RC, Myers RH, Zhang Y, et al. Effects of similarities in lifestyle habits on familial aggregation of high-density lipoprotein and low-density lipoprotein cholesterol: the NHLBI Family Heart Study. Am J Epidemiol. 1999;150:910918.
  • 13
    van Lennep JE, Westerveld HT, van Lennep HW, et al. Apolipoprotein concentrations during treatment and recurrent coronary artery disease events. Arterioscler Thromb Vasc Biol. 2000;20:24082413.
  • 14
    Rubins HB, Robins SJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med. 1999;341:410418.
  • 15
    Rubins HB. Triglycerides and coronary heart disease: implications of recent clinical trials. J Cardiovasc Risk. 2000;7:339345.
  • 16
    Thompson SG, Kienast J, Pyke SD, et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med. 1995;332:635641.
  • 17
    Bogaty P, Poirier P, Simard S, et al. Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina. Circulation. 2001;103:30623068.
  • 18
    Wiman B, Andersson T, Hallqvist J, et al. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. Arterioscler Thromb Vasc Biol. 2000;20:20192023.
  • 19
    Mukamal KJ, Jadhav PP, D'Agostino RB, et al. Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort. Circulation. 2001;104:13671373.
  • 20
    Ridker PM, Vaughan DE, Stampfer MJ, et al. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA. 1994;272:929933.
  • 21
    Smith SC Jr, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutaneous coronary intervention: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). Circulation. 2001;103:30193041.
  • 22
    Deykin D, Janson P, McMahon L. Ethanol potentiation of aspirin-induced prolongation of the bleeding time. N Engl J Med. 1982;306:852854.
  • 23
    Rubin R. Effect of ethanol on platelet function. Alcohol Clin Exp Res. 1999;23:11141118.
  • 24
    Miyamae M, Diamond I, Weiner MW, et al. Regular alcohol consumption mimics cardiac preconditioning by protecting against ischemia-reperfusion injury. Proc Natl Acad Sci U S A. 1997;94:32353239.
  • 25
    Krenz M, Baines CP, Yang XM, et al. Acute ethanol exposure fails to elicit preconditioning-like protection in in situ rabbit hearts because of its continued presence during ischemia. J Am Coll Cardiol. 2001;37:601607.
  • 26
    Wannamethee G, Whincup PH, Shaper AG, et al. Factors determining case fatality in myocardial infarction “who dies in a heart attack”? Br Heart J. 1995;74:324331.
  • 27
    Abramson JL, Williams SA, Krumholz HM, et al. Moderate alcohol consumption and risk of heart failure among older persons. JAMA. 2001;285:19711977.
  • 28
    Delgado CE, Gortuin NJ, Ross RS. Acute effects of low doses of alcohol on left ventricular function by echocardiography. Circulation. 1975;51:535540.
  • 29
    Greenberg BH, Schutz R, Grunkemeier GL, et al. Acute effects of alcohol in patients with congestive heart failure. Ann Intern Med. 1982;97:171175.
  • 30
    Greenspon AJ, Stang JM, Lewis RP, et al. Provocation of ventricular tachycardia after consumption of alcohol. N Engl J Med. 1979;301:10491050.
  • 31
    Siscovick DS, Weiss NS, Fox N. Moderate alcohol consumption and primary cardiac arrest. Am J Epidemiol. 1986;123:499503.
  • 32
    Bernauer W. The effect of ethanol on arrhythmias and myocardial necrosis in rats with coronary occlusion and reperfusion. Eur J Pharmacol. 1986;126:179187.
  • 33
    Palmer AJ, Fletcher AE, Bulpitt CJ, et al. Alcohol intake and cardiovascular mortality in hypertensive patients: report from the Department of Health Hypertension Care Computing Project. J Hypertens. 1995;13:957964.
  • 34
    Solomon CG, Hu FB, Stampfer MJ, et al. Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus. Circulation. 2000;102:494499.
  • 35
    Valmadrid CT, Klein R, Moss SE, et al. Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus. JAMA. 1999;282:239246.
  • 36
    Hein HO, Suadicani P, Gyntelberg F. Alcohol consumption, serum low density lipoprotein cholesterol concentration, and risk of ischaemic heart disease: six year follow up in the Copenhagen male study. BMJ. 1996;312:736741.
  • 37
    Hein HO, Sorensen H, Suadicani P, et al. Alcohol consumption, Lewis phenotypes, and risk of ischaemic heart disease. Lancet. 1993;341:392396.
  • 38
    Thun MJ, Peto R, Lopez AD, et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med. 1997;337:17051714.
  • 39
    Muntwyler J, Hennekens CH, Buring JE, et al. Mortality and light to moderate alcohol consumption after myocardial infarction. Lancet. 1998;352:18821885.
  • 40
    Shaper AG, Wannamethee SG. Alcohol intake and mortality in middle aged men with diagnosed coronary heart disease. Heart. 2000;83:394399.
  • 41
    Mukamal KJ, Maclure M, Muller JE, et al. Prior alcohol consumption and mortality following acute myocardial infarction. JAMA. 2001;285:19651970.
  • 42
    Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998;280:605613.
  • 43
    Rimm EB, Klatsky A, Grobbee D, et al. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits? BMJ. 1996;312:731736.
  • 44
    Cooper HA, Exner DV, Domanski MJ. Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2000;35:17531759.
  • 45
    Goldberg IJ, Mosca L, Piano MR, et al. Wine and your heart: a science advisory for healthcare professionals from the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association. Circulation. 2001;103:472475.